Chemical Compound
myo-Inositol, 1,2,3,4,5,6-hexakis(dihydrogen phosphate); Inositol, hexakis(dihydrogen phosphate), myo- (8CI); myo-Inositol, hexakis(dihydrogen phosphate) (9CI); Alkalovert; Dermofeel PA 3; Exfoderm; Exfoderm Forte; Fytic acid; IP6; Inositol 1,2,3,4,5,6-hexakisphosphate; Inositol hexakis(phosphate); Inositol hexaphosphate; InsP6; Phyliance; Phytic acid; RP 3000; RP 3000 (rust inhibitor); WHL; WHL (depressant); meso-Inositol hexaphosphate; myo-Inositol hexakis(phosphate); myo-Inositol hexaphosphate
CAS Registry Number
83-86-3
Primary record
myo-Inositol, 1,2,3,4,5,6-hexakis(dihydrogen phosphate); Inositol, hexakis(dihydrogen phosphate), myo- (8CI); myo-Inositol, hexakis(dihydrogen phosphate) (9CI); Alkalovert; Dermofeel PA 3; Exfoderm; Exfoderm Forte; Fytic acid; IP6; Inositol 1,2,3,4,5,6-hexakisphosphate; Inositol hexakis(phosphate); Inositol hexaphosphate; InsP6; Phyliance; Phytic acid; RP 3000; RP 3000 (rust inhibitor); WHL; WHL (depressant); meso-Inositol hexaphosphate; myo-Inositol hexakis(phosphate); myo-Inositol hexaphosphate
- 库存
- 4,759 克
- 纯度
- 98.7 %
- CAS
- 83-86-3
化合物标识与属性
- CAS
- 83-86-3
- PubChem CID
- 890
- SMILES
- C1(C(C(C(C(C1OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O
- Canonical SMILES
- O=P(O)(O)OC1C(OP(=O)(O)O)C(OP(=O)(O)O)C(OP(=O)(O)O)C(OP(=O)(O)O)C1OP(=O)(O)O
名称与同义词
- Phytic acid
- Fytic acid
- Alkalovert
- Phytate
- Inositol hexaphosphate
- Acide fytique
- Acido fitico
- Alkovert
- Exfoderm
- 83-86-3
- Phytine
- Acidum fyticum
- myo-Inositol hexaphosphate
- myo-inositol hexakisphosphate
- Phyticacid
- Phyliance
- Phytic acid solution
- Dermofeel pa-3
- phytomonicacid
- Phytin
- Phyton
- fytinsyre-
- Saure des phytins
- Sodium phytate
- InsP6
- Exfoderm Forte
- inositol hexakisphosphate
- hexasodium-phytate
- Inositol, myo-
- 1zsh
- Fytic acid [INN]
- Saeure des phytins
- Dermofeel PA 3
- inositolhexaphosphoric acid
- Inosithexaphosphorsaure
- Phytic Acid Powder
- myo-Inosistol hexakisphosphate
- Inositol hexaphosphoric acid
- InP6
- Inosithexaphosphorsaeure
- Saure des phytins [German]
- Acide fytique [INN-French]
- Acido fitico [INN-Spanish]
- Acidum fyticum [INN-Latin]
- CCRIS 4513
- 1bq3
- meso-Inositol hexaphosphate
- Phytic acid (Standard)
- UNII-7IGF0S7R8I
- Inositol hexakis(phosphate)
- inositol-hexaphosphoric acid
- Phytic acid (potassium)
- AC1Q6SHB
- RefChem:929237
- 7IGF0S7R8I
- myo-Inositol hexakis(phosphate)
- neo-Inositol hexaphosphate
- Phytic acid (dry powder)
- Inosithexaphosphorsaure [German]
- PHYTIC ACID [MI]
- 1D-myo-inositol hexakisphosphate
- D0F3GG
- D0KN1U
- Epitope ID:144992
- Phytic Acid Potassium Salt
- myo-Inositol, hexakis(dihydrogen phosphate)
- C6H18O24P6
- myo-inositol hexaphosphoric acid
- scyllo-Inositol hexaphosphate
- FYTIC ACID [MART.]
- PHYTIC ACID, 40%
- SCHEMBL19249
- D-Glucopyranose, pentaacetate
- FYTIC ACID [WHO-DD]
- CHEBI:17401
- D-chiro inositol hexakisphosphate
- D-chiro-Inositol hexaphosphate
- NSC-269896
- SCHEMBL136587
- EINECS 201-506-6
- GERD therapy (oral), Reviva
- Inositol 1,2,3,4,5,6-hexakisphosphate
- IMQLKJBTEOYOSI-GPIVLXJGSA-N
- IMQLKJBTEOYOSI-UHFFFAOYSA-N
- MFCD00082309
- Phytic Acid (Technical Grade)
- AC1L1A98
- CID890
- IP-6
- orb1304788
- orb3025193
- SCHEMBL1681470
- SCHEMBL1681701
- SCHEMBL1682030
- SCHEMBL9164308
- SCHEMBL9741350
- SNF-03
- SNF-04
- (2,3,4,5,6-pentaphosphonooxycyclohexyl) dihydrogen phosphate
- CHEMBL1233511
- CHEMBL2005481
- myo-inositol hexakis(dihydrogen phosphate)
- NSC 269896
- SCHEMBL12137150
- SCHEMBL12138455
- SCHEMBL12549553
- SCHEMBL15374707
- SCHEMBL17006482
- HY-N0814R
- Phytic Acid (~50% in water)
- diphosphoinositol tetrakisphosphate
- DTXSID00861653
- DTXSID40889331
- MSK2315
- myo-Inositol, 1,2,3,4,5,6-hexakis(dihydrogen phosphate)
- SNF-471
- SNF-472
- SNF-571
- SNF-671
- CHEBI:187038
- IMQLKJBTEOYOSI-OBXALCGXSA-N
- NSC269896
- KST-1B9075
- MYO-INOSITOL HEXAKISPHOSPHAT
- HY-N0814
- Phytic acid, 50% aqueous solution
- ZINC8214655
- D-chiro-Inositol hexaphosphoric acid
- AR-1B5039
- EBC-44249
- L-myo-Inositol hexakisphosphoric acid
- Phytic acid (50% aqueous solution)
- s3793
- E391
- Inositol hexakis(dihydrogen phosphate)
- scyllo-Inositol hexakisphosphoric acid
- AKOS015856604
- AKOS015901448
- C6-H18-O24-P6
- Hexakis(dihydrogen phosphate) myo-inositol
- PHYTIC ACID SOLUTION [USP-RS]
- ZINC169289809
- ZINC169715578
- ZINC169724120
- ZINC195811080
- ZINC216094130
- AC-8037
- AN-8391
- CCG-270338
- CS-6330
- DB14981
- FP15327
- FP59532
- J9.332G
- RL05170
- RP 3000
- RP-3000
- INOSITOL, HEXAKIS(DIHYDROGEN PHOSPHATE), myo-
- myo-Inositol hexakis(dihydrogenphosphate)
- NCGC00483012-01
- BB060737
- FS-10465
- LS-84062
- myo-Inositol 1,2,3,4,5,6-hexakisphosphate
- NCI60_002200
- NCI60_038627
- PD006549
- PD008378
- PD054429
- R238
- SC-11360
- Inositol Hexaphosphate Sodium Salt Hydrate
- Inositol Hexaphosporic Acid, Hexaphosphate
- D-myo-Inositol 1,2,3,4,5,6-hexakisphosphate
- Phytic acid solution 50 % (w/w) in H2O
- 1D-myo-Inositol 1,2,3,4,5,6-hexakisphosphate
- FT-0600486
- FT-0689105
- FT-0777723
- N1645
- NS00007450
- NS00122262
- P0409
- Phytic acid solution, 50 % (w/w) in H2O
- ST24031538
- D-myo-Inositol 1,2,3,4,5,6-hexaphosphate
- D-myo-Inositol-1,2,3,4,5,6-hexaphosphate
- J1.438.350F
- J1.747.284D
- J2.250.016C
- J3.054.332G
- A11614
- A14529
- C01204
- Phytic acid solution, technical, ~40% in H2O
- inositol polyphosphate, inositol hexakisphosphate
- IP6
- 1,2,3,4,5,6-cyclohexanehexol, hexakis(dihydrogen phosphate)
- EN300-19650970
- Q409679
- SR-01000944523
- INOSITOL HEXAPHOSPHORIC ACID DIPOTASSIUM SALT
- Phytic Acid (ca. 50% in Water, ca. 1.1mol/L)
- SR-01000944523-1
- BRD-K70007857-001-01-7
- Gastroesophageal reflux disease therapy (oral), Reviva
- I14-15308
- L-myo-Inositol 1,2,3,4,5,6-hexakisphosphoric acid
- myo-Inositol 1,2,3,4,5,6-Hexakis(dihydrogen phosphate)
- SNF-571 (transdermal patch, renal calcium lithiasis), Sanifit
- (1R,2S,3r,4R,5S,6s)-cyclohexane-1,2,3,4,5,6-hexayl hexakis[dihydrogen (phosphate)]
- {[2,3,4,5,6-pentakis(phosphonooxy)cyclohexyl]oxy}phosphonic acid
- cyclohexane-1,2,3,4,5,6-hexayl hexakis[dihydrogen (phosphate)]
- D-myo-Inositol 1,2,3,4,5,6-Hexakisphosphate Sodium Salt Hydrate, Zea mays (>85% purity)
- Phytate (tablet formulation, osteoporosis), Sanifit Laboratoris SL
- rel-(1R,2r,3S,4R,5s,6S)-Cyclohexane-1,2,3,4,5,6-hexayl hexakis(dihydrogen phosphate)
- SNF-471 (transdermal patch, cardiovascular calcification), Sanifit
- (1S,3'S)-3'-acetyl-3'-methylspiro[naphthalene-1,2'-oxirane]-2-one
- {[(2r,3r)-2,3,4,5,6-pentakis(phosphonooxy)cyclohexyl]oxy}phosphonic acid
- {[(2r,5r)-2,3,4,5,6-pentakis(phosphonooxy)cyclohexyl]oxy}phosphonic acid
- 10083-08-6
- 33705-24-7
- 89602-25-5
- IHP
- Phosphoric acid mono-(2,3,4,5,6-pentakis-phosphonooxy-cyclohexyl) este
- Phosphoric acid mono-(2,3,4,5,6-pentakis-phosphonooxy-cyclohexyl) ester
- Phytic acid solution, United States Pharmacopeia (USP) Reference Standard
- (1R,2S,3r,4R,5S,6s)-1,2,3,4,5,6-Cyclohexanehexayl hexakis[dihydrogen (phosphate)]
- [(1S,2R,3r,4S,5R,6S)-2,3,4,5,6-pentakis(phosphonooxy)cyclohexyl]oxyphosphonic acid
- {[(1r,2r,3r,4r,5r,6r)-2,3,4,5,6-pentakis(phosphonooxy)cyclohexyl]oxy}phosphonic acid
- {[(1r,2R,3S,4s,5R,6S)-2,3,4,5,6-pentakis(phosphonooxy)cyclohexyl]oxy}phosphonic acid
- InsP6 (transdermal patch formulation, cardiovascular calcifications), Sanifit Laboratoris SL
- InsP6, (transdermal/patch formulation, renal calcium lithiasis), Sanifit Laboratoris SL
- MYO-INOSITOL HEXAKISPHOSPHATE; INOSITOL 1,2,3,4,5,6-HEXAKISPHOSPHATE
- Myo-inositol hexaphosphate (tablet formulation, osteoporosis), Sanifit Laboratoris SL
- MYO-INOSITOL, 1,2,3,4,5,6-HEXAKIS(DIHYDROGEN PHOSPHATE),60% IN WATER
- Phytate (intravenous formulation, cardiovascular calcifications), Sanifit Laboratoris SL
- Phytate (transdermal/patch formulation, renal calcium lithiasis), Sanifit Laboratoris SL
- rel-(1R,2r,3S,4R,5s,6S)-Cyclohexane-1,2,3,4,5,6-hexaylhexakis(dihydrogenphosphate)
- 1,2,3,4,5,6-cyclohexanehexol, hexakis(dihydrogen phosphate), (1alpha,2alpha,3alpha,4beta,5alpha,6beta)-
- 129833-03-0
- 3615-82-5
- 503-06-0
- 7776-28-5
- Calcium metabolism modulator (subcutaneous/injectable formulation, cardiovascular calcifications), Sanifit Laboratoris SL
- Calcium metabolism modulator (transdermal patch formulation, cardiovascular calcifications), Sanifit Laboratoris SL
- KGN
- Myo-inositol hexakisphosphate (transdermal patchformulation, cardiovascular calcifications), Sanifit Laboratoris SL
- Myo-inositol hexaphosphate (intravenous formulation, cardiovascular calcifications), Sanifit Laboratoris SL
- Myo-inositol hexaphosphate (transdermal patch formulation, cardiovascular calcifications), Sanifit Laboratoris SL
- Myo-inositol hexaphosphate (transdermal/patch formulation, renal calcium lithiasis), Sanfit Laboratoris SL
- myo-Inositol, 1,2,3,4,5,6-hexakis(dihydrogen phosphate); Inositol, hexakis(dihydrogen phosphate), myo- (8CI); myo-Inositol, hexakis(dihydrogen phosphate) (9CI); Alkalovert; Dermofeel PA 3; Exfoderm; Exfoderm Forte; Fytic acid; IP6; Inositol 1,2,3,4,5,6-hexakisphosphate; Inositol hexakis(phosphate); Inositol hexaphosphate; InsP6; Phyliance; Phytic acid; RP 3000; RP 3000 (rust inhibitor); WHL; WHL (depressant); meso-Inositol hexaphosphate; myo-Inositol hexakis(phosphate); myo-Inositol hexaphosphate
- Phytate (transdermal patch formulation, cardiovascular calcifications), Sanifit Laboratoris SL
- Potassium Phytate; IP6 Potassium Salt; Inositol Hexaphosphate Potassium Salt; Hexakis(dihydrogen phosphate)-myo-inositol Potassium Salt;
- WHL